77 related articles for article (PubMed ID: 22334317)
1. One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry.
Neumann FJ; Widimsky P; Belardi JA
EuroIntervention; 2012 Feb; 7(10):1181-8. PubMed ID: 22334317
[TBL] [Abstract][Full Text] [Related]
2. Resolute Italian study in all comers: immediate and one-year outcomes.
Romagnoli E; Godino C; Ielasi A; Gasparini G; Tzifos V; Sciahbasi A; Lioy E; Presbitero P; Colombo A; Sangiorgi G
Catheter Cardiovasc Interv; 2012 Mar; 79(4):567-74. PubMed ID: 21805557
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
von Birgelen C; Basalus MW; Tandjung K; van Houwelingen KG; Stoel MG; Louwerenburg JH; Linssen GC; Saïd SA; Kleijne MA; Sen H; Löwik MM; van der Palen J; Verhorst PM; de Man FH
J Am Coll Cardiol; 2012 Apr; 59(15):1350-61. PubMed ID: 22341737
[TBL] [Abstract][Full Text] [Related]
4. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial.
Silber S; Windecker S; Vranckx P; Serruys PW;
Lancet; 2011 Apr; 377(9773):1241-7. PubMed ID: 21459430
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program.
Silber S; Serruys PW; Leon MB; Meredith IT; Windecker S; Neumann FJ; Belardi J; Widimsky P; Massaro J; Novack V; Yeung AC; Saito S; Mauri L
JACC Cardiovasc Interv; 2013 Apr; 6(4):357-68. PubMed ID: 23523454
[TBL] [Abstract][Full Text] [Related]
6. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program.
Yeh RW; Silber S; Chen L; Chen S; Hiremath S; Neumann FJ; Qiao S; Saito S; Xu B; Yang Y; Mauri L
JACC Cardiovasc Interv; 2017 Feb; 10(3):247-254. PubMed ID: 28109872
[TBL] [Abstract][Full Text] [Related]
7. One-year outcomes from an all-comers chinese population of patients implanted with the resolute zotarolimus-eluting stent.
Qiao S; Chen L; Chen S; Wang W; Zhu G
Am J Cardiol; 2014 Feb; 113(4):613-20. PubMed ID: 24365120
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea registries.
Park KW; Lee JM; Kang SH; Ahn HS; Yang HM; Lee HY; Kang HJ; Koo BK; Cho J; Gwon HC; Lee SY; Chae IH; Youn TJ; Chae JK; Han KR; Yu CW; Kim HS
J Am Coll Cardiol; 2013 Feb; 61(5):536-44. PubMed ID: 23273394
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
10. The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention).
Stefanini GG; Serruys PW; Silber S; Khattab AA; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; Di Mario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli AL; Gobbens P; Windecker S
J Am Coll Cardiol; 2011 May; 57(22):2221-32. PubMed ID: 21616282
[TBL] [Abstract][Full Text] [Related]
11. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL
Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585
[TBL] [Abstract][Full Text] [Related]
12. Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial.
Kang WC; Ahn T; Lee K; Han SH; Shin EK; Jeong MH; Yoon JH; Park JS; Bae JH; Hur SH; Rha SW; Oh SK; Kim DI; Jang Y; Choi JW; Kim BO
EuroIntervention; 2011 Dec; 7(8):936-43. PubMed ID: 21959255
[TBL] [Abstract][Full Text] [Related]
13. Extended follow-up safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: two-year follow-up from the E-Five Registry.
Meredith I; Rothman M; Erglis A; Parikh K; Lotan C;
Catheter Cardiovasc Interv; 2011 Jun; 77(7):993-1000. PubMed ID: 20853351
[TBL] [Abstract][Full Text] [Related]
14. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
[TBL] [Abstract][Full Text] [Related]
15. Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry.
Tommasino A; Burzotta F; Sciahbasi A; Trani C; De Vita M; Romagnoli E; Lioy E; Tarantino F; Summaria F; Leone AM; Porto I; Niccoli G; Mongiardo R; Mazzari MA; Schiavoni G; Crea F
J Invasive Cardiol; 2011 Feb; 23(2):50-4. PubMed ID: 21297199
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program.
Di Mario C; Serruys PW; Silber S; Lu S; Wang W; Widimský P; Xu B; Windecker S
EuroIntervention; 2016 Nov; 12(10):1207-1214. PubMed ID: 27866129
[TBL] [Abstract][Full Text] [Related]
17. Unrestricted use of endeavor resolute zotarolimus-eluting stent in daily clinical practice: a prospective registry.
Galasso G; Piccolo R; Cassese S; Esposito G; Cirillo P; Leosco D; Rapacciuolo A; Sirico D; De Biase C; Niglio T; Piscione F
J Invasive Cardiol; 2012 Jun; 24(6):251-5. PubMed ID: 22684376
[TBL] [Abstract][Full Text] [Related]
18. Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study).
Van den Branden BJ; Rahel BM; Laarman GJ; Slagboom T; Kelder JC; Ten Berg JM; Suttorp MJ
EuroIntervention; 2012 Feb; 7(10):1189-96. PubMed ID: 22030323
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
